Unicycive Therapeutics, Inc. Common Stock

Go to Unicycive Therapeutics, Inc. Common Stock Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$38.7 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

– OLC Demonstrates Bioequivalence to Lanthanum Carbonate –

Related tickers: UNCY.

Read Full Article

– On Track to Provide Topline Data from the Ongoing Pivotal Clinical Trial with Oxylanthanum Carbonate (OLC) in Q2 2024 –

Related tickers: UNCY.

Read Full Article
Trending Tickers
ITOS

XNAS

$0.00
(%)
MIMO

XASE

$0.00
(%)
PRSO

XNAS

$0.00
(%)
QQQ

XNAS

$451.98
(%)
$0.31
(%)